90 related articles for article (PubMed ID: 22743615)
1. LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma.
Chen H; Ko JM; Wong VC; Hyytiainen M; Keski-Oja J; Chua D; Nicholls JM; Cheung FM; Lee AW; Kwong DL; Chiu PM; Zabarovsky ER; Tsao SW; Tao Q; Kan R; Chan SH; Stanbridge EJ; Lung ML
Cancer Lett; 2012 Dec; 325(1):89-98. PubMed ID: 22743615
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
[TBL] [Abstract][Full Text] [Related]
3. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma.
Law EW; Cheung AK; Kashuba VI; Pavlova TV; Zabarovsky ER; Lung HL; Cheng Y; Chua D; Lai-Wan Kwong D; Tsao SW; Sasaki T; Stanbridge EJ; Lung ML
Oncogene; 2012 Feb; 31(6):728-38. PubMed ID: 21743496
[TBL] [Abstract][Full Text] [Related]
5. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma.
He D; Zeng Q; Ren G; Xiang T; Qian Y; Hu Q; Zhu J; Hong S; Hu G
Eur J Cancer Prev; 2012 Nov; 21(6):569-75. PubMed ID: 22273848
[TBL] [Abstract][Full Text] [Related]
6. The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome.
Chan SH; Yee Ko JM; Chan KW; Chan YP; Tao Q; Hyytiainen M; Keski-Oja J; Law S; Srivastava G; Tang J; Tsao SW; Chen H; Stanbridge EJ; Lung ML
Int J Cancer; 2011 Aug; 129(3):565-73. PubMed ID: 20878956
[TBL] [Abstract][Full Text] [Related]
7. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
8. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
9. Kank1 reexpression induced by 5-Aza-2'-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis.
Luo FY; Xiao S; Liu ZH; Zhang PF; Xiao ZQ; Tang CE
Int J Clin Exp Pathol; 2015; 8(2):1658-65. PubMed ID: 25973051
[TBL] [Abstract][Full Text] [Related]
10. Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.
Chen T; Long B; Ren G; Xiang T; Li L; Wang Z; He Y; Zeng Q; Hong S; Hu G
J Cell Biochem; 2015 Aug; 116(8):1766-75. PubMed ID: 25736877
[TBL] [Abstract][Full Text] [Related]
11. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z
BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455
[TBL] [Abstract][Full Text] [Related]
12. IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.
Phoon YP; Cheung AK; Cheung FM; Chan KF; Wong S; Wong BW; Tung SY; Yau CC; Ng WT; Lung ML
Int J Cancer; 2016 Jan; 138(1):160-70. PubMed ID: 26227166
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
14. Increase in IkappaB kinase alpha expression suppresses the tumor progression and improves the prognosis for nasopharyngeal carcinoma.
Deng L; Li Y; Ai P; Xie Y; Zhu H; Chen N
Mol Carcinog; 2015 Feb; 54(2):156-65. PubMed ID: 24753359
[TBL] [Abstract][Full Text] [Related]
15. CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma.
Du C; Huang T; Sun D; Mo Y; Feng H; Zhou X; Xiao X; Yu N; Hou B; Huang G; Ernberg I; Zhang Z
Cancer Lett; 2011 Oct; 309(1):54-61. PubMed ID: 21665361
[TBL] [Abstract][Full Text] [Related]
16. NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells.
Kan R; Shuen WH; Lung HL; Cheung AK; Dai W; Kwong DL; Ng WT; Lee AW; Yau CC; Ngan RK; Tung SY; Lung ML
PLoS One; 2015; 10(5):e0127239. PubMed ID: 25974126
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA Hotair mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways.
Fu WM; Lu YF; Hu BG; Liang WC; Zhu X; Yang HD; Li G; Zhang JF
Oncotarget; 2016 Jan; 7(4):4712-23. PubMed ID: 26717040
[TBL] [Abstract][Full Text] [Related]
18. NOR1 is an HSF1- and NRF1-regulated putative tumor suppressor inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
Li W; Li X; Wang W; Li X; Tan Y; Yi M; Yang J; McCarthy JB; Xiong W; Wu M; Ma J; Su B; Zhang Z; Liao Q; Xiang B; Li G
Carcinogenesis; 2011 Sep; 32(9):1305-14. PubMed ID: 21803736
[TBL] [Abstract][Full Text] [Related]
19. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
Li J; Gong P; Lyu X; Yao K; Li X; Peng H
Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
[TBL] [Abstract][Full Text] [Related]
20. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
